Nalaganje...
Pump Users Clamor for Faster Insulin: Is Fast-Acting Insulin Aspart Ready for Them?
Recently approved in Europe, Canada, and the United States, fast-acting insulin aspart (FIASP®) is a new rapid acting insulin. Approved for subcutaneous or IV injection use, there is little data available regarding the clinical utility of FIASP in insulin pumps. The article by Zijlstra and colleague...
Shranjeno v:
| izdano v: | J Diabetes Sci Technol |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5761999/ https://ncbi.nlm.nih.gov/pubmed/29291651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296817750166 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|